The Value of Precision Medicine

Vivian Lee, Ph.D., M.D., M.B.A., CEO of University of Utah Health Care and vice president of University of Utah Health Sciences explains why creating a genetic and medical database is of national interest. She cites discoveries made through the Utah Population Database - genetic causes of breast cancer, colon cancer, mealonoma and other diseases - as evidecne that investing in such a resource pays rich dividends. Her op-ed was published in Fortune Magazine.

What Obama’s SOTU Should Say About Personalized Medicine

A national database of genetic and medical information will disrupt health care.

In last year’s State of the Union address, President Obama introduced an initiative to advance precision medicine — an approach to healthcare that offers the promise of diagnosing, preventing, and treating disease, guided by a patient’s own biological profile and the medical industry’s growing knowledge about the genetic roots of disease. Precision medicine could revolutionize medical care. Also, it could either wreck or save the finances of our America’s healthcare system.

Biomedical data is the cornerstone of precision medicine — the more we know about a patient and her disease, the more precisely providers can target a personalized treatment. In his final State of the Union address tonight, President Obama is expected to discuss the creation of a national database of genetic and medical information — voluntarily supplied by 1 million Americans — that will fuel research on the genetics of cancer, cystic fibrosis, and other diseases. Paralleling this federal effort, institutions across the country are creating biomedical databases to help them better understand how their patients’ genetic variations cause — or prevent — illness.

Read the article in Fortune Magazine

History shows these investments pay enormous dividends